MyFinsight
Home
About
Contact
mira: the income statement
Download
Download image
Net loss
attributable to common...
-$22,694,494
Unrealized gain on
short-term investments
$176,056
Interest income
$15,697
Deemed dividend
$21,556,821
Net loss
-$1,137,673
(44.34%↑ Y/Y)
Other income,
expense, net
$179,312
Other expense
$12,441
Total operating costs
$1,316,985
(-36.73%↓ Y/Y)
Research and development
expenses
$412,639
(-61.34%↓ Y/Y)
General and
administrative expenses
$904,346
(-10.83%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)